Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases

NCT01781026

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States

View Trial Details

Completed

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT01390818

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +37 more
Locations: Pinnacle Oncology Hematology Scottsdale, Arizona, United States

Cedars Sinai Medical Center Los Angeles, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine

NCT00861406

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study

NCT02618694

Conditions: Adrenal Disease, Adrenal Gland Diseases, Adrenal Mass, +11 more
Locations: Alexandria Main University Hospital Alexandria, Alexandria Governorate, Egypt

Suez Canal University Hospital Ismailia, Ismailia Governorate, Egypt

View Trial Details

Completed

Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma

NCT00323206

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma

NCT00418496

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +23 more
Locations: Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

NCT00003895

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +18 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

NCT00553306

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer

NCT00118248

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Endostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT02104323

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: Beijing Tiantan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions